News & Stories
We bring together unparalleled knowledge and experience in smart, randomized controlled trial design with the use of data and technology to transform both the quality and affordability of clinical trials.
“A New National Purpose”: Protas named in report on innovation
Protas was this week named in a new report exploring how the UK should harness innovation in science and technology in order to safeguard its future.Read More
The Lancet published a Research Focus article on Protas, based on interviews with Protas CEO Sir Martin Landray as well...